Androgens and Bone

Vanderschueren, Dirk, Vandenput, Liesbeth, Boonen, Steven, Lindberg, Marie K., Bouillon, Roger, Ohlsson, Claes·2004·Endocrine Reviews
DOI 10.1210/er.2003-0003

Cites (448)

Items 401–448 of 448

  1. Spironolactone, But Not Flutamide, Administration Prevents Bone Loss in Hyperandrogenic Women Treated with Gonadotropin-Releasing Hormone Agonist1
    Paolo Moghetti, Roberto Castello, Nicoletta Zamberlan, Maurizio Rossini, Davide Gatti, Carlo Negri, Flavia Tosi, Michele Muggeo, S. Adámi · 1999 · The Journal of Clinical Endocrinology & Metabolism
  2. Physiological plasma levels of androgens reduce bone loss in the ovariectomized rat
    C. K. Lea, Adrienne Margaret Flanagan · 1998 · American Journal of Physiology-Endocrinology and Metabolism
  3. Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess
    Janez Preželj, Anja Kocijancic · 1994 · Hormone and Metabolic Research
  4. Forearm mineral content in normal men: Relationship to weight, height and plasma testosterone concentrations
    A. McElduff, M. Wilkinson, Peter Ward, Solomon Posen · 1988 · Bone
  5. Ovarian androgens protect against bone loss in rats made oestrogen deficient by treatment with ICI 182,780
    C. K. Lea, Adrienne Margaret Flanagan · 1999 · Journal of Endocrinology
  6. Finasteride therapy does not alter bone turnover in men with benign prostatic hyperplasia--a Clinical Research Center study
    Steven R. Tollin, Harold N. Rosen, K Zurowski, Brian Saltzman, A J Zeind, Sandra J. Berg, S. L. Greenspan · 1996 · The Journal of Clinical Endocrinology & Metabolism
  7. Excess androgenicity only partially explains the relationship between obesity and bone density in premenopausal women.
    Haffner Sm, RL Bauer · 1992 · PubMed
  8. Osteoporosis and osteoporotic fractures in men: a clinical perspective
    Dirk Vanderschueren, Steven Boonen, Roger Bouillon · 2000 · Best Practice & Research Clinical Endocrinology & Metabolism
  9. Effects of 17β-estradiol administration on cortical and cancellous bone of ovariectomized rats with and without hypophysectomy
    J. K. Yeh, M.M. Chen, John F. Aloia · 1997 · Bone
  10. Distribution of 17β-hydroxysteroid dehydrogenases in human osteoblast-like cells
    Maritta Feix, Lutz Wolf, Hans‐Udo Schweikert · 2001 · Molecular and Cellular Endocrinology
  11. Study of androgen action in bone by analysis of androgen-receptor deficient mice
    Takashi Sato, Hirotaka Kawano, Shigeaki Kato · 2002 · Journal of Bone and Mineral Metabolism
  12. Short-Term effects of high dose estrogen on tibiae of growing male rats
    Glenn K. Wakley, Glenda L. Evans, Russell T. Turner · 1997 · Calcified Tissue International
  13. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells
    Donald G. Phinney, Gene C. Kopen, William Righter, Stephen Webster, Nicola Tremain, Darwin J. Prockop · 1999 · Journal of Cellular Biochemistry
  14. Osteoporosis in men.
    D. C. Anderson · 1992 · BMJ
  15. Cancer of the corpus uteri in white and black women in Michigan, 1985-1994
    Terri Madison, David Schottenfeld, Vicki M. Baker · 1998 · Cancer
  16. Effect of antiandrogens casodex and epitestosterone on bone composition in mice
    P. D. Broulik, Luboslav Stárka · 1997 · Bone
  17. Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogen
    C. K. Lea, V. Moxham, Michael J. Reed, Adrienne Margaret Flanagan · 1998 · Journal of Endocrinology
  18. Estrogen-induced osteogenesis in intact female mice lacking ERβ
    K. E. McDougall, M. J. Perry, Rachel Gibson, J. M. Bright, Shane M. Colley, Jeffrey B. Hodgin, Oliver Smithies, Jonathan H. Tobias · 2002 · American Journal of Physiology-Endocrinology and Metabolism
  19. Estrogen-androgen for hormone replacement. A review.
    M. J. Rosenberg, Tony King, M. Chrystie Timmons · 1997 · PubMed
  20. Evidence of a Correlation of Estrogen Receptor Level and Avian Osteoclast Estrogen Responsiveness
    Larry G. Pederson, Matthew Kremer, Niels Taekker Foged, Bent Winding, Candace K. Ritchie, Lorraine A. Fitzpatrick, Merry Jo Oursler · 1997 · Journal of Bone and Mineral Research
  21. Sex hormones mediate interleukin-1β production by human osteoblastic HOBIT cells
    Louis A. Pivirotto, David S. Cissel, Philip E. Keeting · 1995 · Molecular and Cellular Endocrinology
  22. Androgen-Receptor Blockade Does Not Impair Bone Mineral Density in Adolescent Females
    Silvano Bertelloni, Giampiero Igli Baroncelli, M. C. Sorrentino, Sabrina Costa, Roberta Battini, Giuseppe Saggese · 1997 · Calcified Tissue International
  23. Estrogen receptor mRNA is expressed in vivo in rat calvarial periosteum
    Kim C. Westerlind, Gobinda Sarkar, Mark E. Bolander · 1995 · Steroids
  24. Functional estrogen in a human preosteoclastic cell line
    Gianna Fiorelli · 1995 · Medical Entomology and Zoology
  25. Demonstration of isoforms of the estrogen receptor in the bone tissues and in osteoblastic cells
    S. Hoshino, Satoshi Inoue, Takayuki Hosoi · 1995 · Calcified Tissue International
  26. Gonadal Steroids and Bone Metabolism in Young Castrated Male Rats
    Nathalie Meunier, Véronique Coxam, Simon P. Robins, Philippe Pastoureau, Alain Pointillart, Marie-Jeanne Davicco, Patrice Lebecque, J.P. Barlet · 2000 · Calcified Tissue International
  27. Casodex (a Nonsteroidal Antiandrogen) Reduces Cancellous, Endosteal, and Periosteal Bone Formation in Estrogen-Replete Female Rats
    C. K. Lea, Nicholas Kendall, Adrienne Margaret Flanagan · 1996 · Calcified Tissue International
  28. The Estrogen Receptor Ligand ICI 182,780 Does Not Impair the Bone-Sparing Effects of Testosterone in the Young Orchidectomized Rat Model
    Liesbeth Vandenput, Johannes V. Swinnen, Eric Van Herck, Annemieke Verstuyf, Steven Boonen, Roger Bouillon, Dirk Vanderschueren · 2002 · Calcified Tissue International
  29. Effects of retinoic acid on steroid and vitamin D3 receptors in cultured mouse osteosarcoma cells
    Sadao Suzuki, M. Koga, Kunio Takaoka · 1993 · Bone
  30. 3.BETA.-Hydroxysteroid Dehydrogenase Activity in Human Osteoblast-Like Cells.
    Yuzuru Kuwano, HIROSHI FUJIKAWA, Akira Watanabe, Kazuhisa Shimodaira, Akihiko Sekizawa, HIROSHI SAITO, T Yanaihara · 1997 · Endocrine Journal
  31. Spironolactone, But Not Flutamide, Administration Prevents Bone Loss in Hyperandrogenic Women Treated With Gonadotropin-Releasing Hormone Agonist
    Paolo Moghetti, Roberto Castello, Nicoletta Zamberlan, Maurizio Rossini, Davide Gatti, Carlo Negri, Flavia Tosi, Michele Muggeo, S. Adámi · 1999 · Obstetrical & Gynecological Survey
  32. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty
    E. Schonau · 1996 · The Journal of Clinical Endocrinology & Metabolism
  33. A comparison of microanatomic basis for coupling between bone formation and bone resorption in man and the rat
    Jade W. M. Chow, Sunil Badve, Timothy John Chambers · 1993 · Bone
  34. Androgens contribute to the stimulation of cancellous bone formation by ovarian hormones in female rats
    Andrea C Gallagher, T.J. Chambers, Jonathan H. Tobias · 1996 · American Journal of Physiology-Endocrinology and Metabolism
  35. Sex steroids, ANGELS and osteoporosis
    Jonathan G. Moggs, Damian G. Deavall, George M. Orphanides · 2003 · BioEssays
  36. Restoring Aging Bones
    Clifford J. Rosen · 2003 · Scientific American
  37. Tamoxifen Prevents Bone Loss in Castrated Male Mice
    P. D. Broulik · 2000 · Hormone and Metabolic Research
  38. The High-Affinity Estrogen Receptor Antagonist ICI 182,780 Has No Effect on Bone Growth in Young Male Rats
    Russell T. Turner, Glenda L. Evans, Harald Dobnig · 2000 · Calcified Tissue International
  39. Regulation of Bone Cell Function by Estrogens
    B. Komm, P. Bodine · 2001 · Elsevier eBooks
  40. Effects of Calcium Deprivation and Orchidectomy on Bone Composition in the Rat
    Alison J Hodgkinson · 1979 · Hormone and Metabolic Research
  41. Reduced Calcitonin Reserve in Young Hypogonadic Osteoporotic Men
    Carlo Foresta, Giovanni Scanelli, Gustavo Batistin Zanatta · 1987 · Hormone and Metabolic Research
  42. Absence of androgen-mediated transcriptional effects in osteoblastic cells despite presence of androgen receptors
    Frank S. Czerwiec, Jiin‐Jia Liaw, S.-B. Liu, Carlos Perez‐Stable, Robert M. Grumbles, Guy A. Howard, Bernard A. Roos, Kerry L. Burnstein · 1997 · Bone
  43. A Scanning Electron-Microscopic Study of Femoral Bone Surfaces from Castrate Rats Treated with Dichloromethylene Biphosphonate
    Carole S. Wink · 1986 · Cells Tissues Organs
  44. Effects of Long Term Treatment With Finasteride (MK-906), a 5-Alpha Reductase Inhibitor, on Circulating LH, FSH, Prolactin and Estradiol
    H. Matzkin, J. Chen, Orly Lewyshon · 1992 · Hormone and Metabolic Research
  45. Gonadal Steroids and the Skeleton in Men
    Benjamin Z. Leder, Joel S. Finkelstein · 2003 · Humana Press eBooks
  46. Evidence for Plasma Membrane-Mediated Effects of Estrogen
    Carol V. Gay, Kristen D. Brubaker · 1999 · Calcified Tissue International
  47. Gonadal Steroids and the Skeleton in Men: Clinical Aspects
    Benjamin Z. Leder, Joel S. Finkelstein · 2003 · Humana Press eBooks
  48. Anabolic effects of testosterone on bone require the presence of a functional androgen receptor in male mice
    Liesbeth Vandenput, Steven Boonen, Reinhold G. Erben · 2002 · Journal of Bone and Mineral Research